Literature DB >> 23792207

AutoGrow 3.0: an improved algorithm for chemically tractable, semi-automated protein inhibitor design.

Jacob D Durrant1, Steffen Lindert, J Andrew McCammon.   

Abstract

We here present an improved version of AutoGrow (version 3.0), an evolutionary algorithm that works in conjunction with existing open-source software to automatically optimize candidate ligands for predicted binding affinity and other druglike properties. Though no substitute for the medicinal chemist, AutoGrow 3.0, unlike its predecessors, attempts to introduce some chemical intuition into the automated optimization process. AutoGrow 3.0 uses the rules of click chemistry to guide optimization, greatly enhancing synthesizability. Additionally, the program discards any growing ligand whose physical and chemical properties are not druglike. By carefully crafting chemically feasible druglike molecules, we hope that AutoGrow 3.0 will help supplement the chemist's efforts. To demonstrate the utility of the program, we use AutoGrow 3.0 to generate predicted inhibitors of three important drug targets: Trypanosoma brucei RNA editing ligase 1, peroxisome proliferator-activated receptor γ, and dihydrofolate reductase. In all cases, AutoGrow generates druglike molecules with high predicted binding affinities. AutoGrow 3.0 is available free of charge (http://autogrow.ucsd.edu) under the terms of the GNU General Public License and has been tested on Linux and Mac OS X.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autogrow; Click chemistry; Computational chemistry; Drug design

Mesh:

Substances:

Year:  2013        PMID: 23792207      PMCID: PMC3842281          DOI: 10.1016/j.jmgm.2013.05.006

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  40 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Antimicrobial dihydrofolate reductase inhibitors--achievements and future options: review.

Authors:  R L Then
Journal:  J Chemother       Date:  2004-02       Impact factor: 1.714

Review 3.  Computer-based de novo design of drug-like molecules.

Authors:  Gisbert Schneider; Uli Fechner
Journal:  Nat Rev Drug Discov       Date:  2005-08       Impact factor: 84.694

Review 4.  Successful applications of computer aided drug discovery: moving drugs from concept to the clinic.

Authors:  Tanaji T Talele; Santosh A Khedkar; Alan C Rigby
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 5.  Concepts and applications of "natural computing" techniques in de novo drug and peptide design.

Authors:  Jan A Hiss; Markus Hartenfeller; Gisbert Schneider
Journal:  Curr Pharm Des       Date:  2010-05       Impact factor: 3.116

Review 6.  A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer.

Authors:  A A Adjei
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

7.  Potential drug-like inhibitors of Group 1 influenza neuraminidase identified through computer-aided drug design.

Authors:  Jacob D Durrant; J Andrew McCammon
Journal:  Comput Biol Chem       Date:  2010-04-03       Impact factor: 2.877

8.  NNScore 2.0: a neural-network receptor-ligand scoring function.

Authors:  Jacob D Durrant; J Andrew McCammon
Journal:  J Chem Inf Model       Date:  2011-11-03       Impact factor: 4.956

9.  Functional and structural insights revealed by molecular dynamics simulations of an essential RNA editing ligase in Trypanosoma brucei.

Authors:  Rommie E Amaro; Robert V Swift; J Andrew McCammon
Journal:  PLoS Negl Trop Dis       Date:  2007-11-14

10.  A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology.

Authors:  Jacob D Durrant; Rommie E Amaro; Lei Xie; Michael D Urbaniak; Michael A J Ferguson; Antti Haapalainen; Zhijun Chen; Anne Marie Di Guilmi; Frank Wunder; Philip E Bourne; J Andrew McCammon
Journal:  PLoS Comput Biol       Date:  2010-01-22       Impact factor: 4.475

View more
  14 in total

1.  High accuracy in silico sulfotransferase models.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

Review 2.  Open source molecular modeling.

Authors:  Somayeh Pirhadi; Jocelyn Sunseri; David Ryan Koes
Journal:  J Mol Graph Model       Date:  2016-07-30       Impact factor: 2.518

3.  Computational identification of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120.

Authors:  Alexander M Andrianov; Ivan A Kashyn; Alexander V Tuzikov
Journal:  J Mol Model       Date:  2017-01-03       Impact factor: 1.810

Review 4.  Computational polypharmacology: a new paradigm for drug discovery.

Authors:  Rajan Chaudhari; Zhi Tan; Beibei Huang; Shuxing Zhang
Journal:  Expert Opin Drug Discov       Date:  2017-01-23       Impact factor: 6.098

5.  Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets.

Authors:  William J Allen; Brian C Fochtman; Trent E Balius; Robert C Rizzo
Journal:  J Comput Chem       Date:  2017-09-22       Impact factor: 3.376

6.  DeepFrag: An Open-Source Browser App for Deep-Learning Lead Optimization.

Authors:  Harrison Green; Jacob D Durrant
Journal:  J Chem Inf Model       Date:  2021-05-24       Impact factor: 4.956

Review 7.  In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery.

Authors:  Lauro Ribeiro de Souza Neto; José Teófilo Moreira-Filho; Bruno Junior Neves; Rocío Lucía Beatriz Riveros Maidana; Ana Carolina Ramos Guimarães; Nicholas Furnham; Carolina Horta Andrade; Floriano Paes Silva
Journal:  Front Chem       Date:  2020-02-18       Impact factor: 5.221

Review 8.  A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets.

Authors:  Michael J Wasko; Kendy A Pellegrene; Jeffry D Madura; Christopher K Surratt
Journal:  Front Neurol       Date:  2015-09-11       Impact factor: 4.003

9.  pMD-Membrane: A Method for Ligand Binding Site Identification in Membrane-Bound Proteins.

Authors:  Priyanka Prakash; Abdallah Sayyed-Ahmad; Alemayehu A Gorfe
Journal:  PLoS Comput Biol       Date:  2015-10-27       Impact factor: 4.475

10.  Exploring the chemical space of influenza neuraminidase inhibitors.

Authors:  Nuttapat Anuwongcharoen; Watshara Shoombuatong; Tanawut Tantimongcolwat; Virapong Prachayasittikul; Chanin Nantasenamat
Journal:  PeerJ       Date:  2016-04-19       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.